Literature DB >> 26497178

Hepatitis C virus genotypes in Kenya.

Joseph Mwangi1,2, Zipporah Nganga3, Solomon Mpoke4, Raphael Lihana5, Joyceline Kinyua5, Nancy Lagat5, Joseph Muriuki5, Rency Lel5, Sheila Kageha5, Saida Osman5, Hiroshi Ichimura6.   

Abstract

Hepatitis C virus is a great public-health concern worldwide. Phylogenetic analysis of the HCV genome has identified six different genotypes that have generally been divided into several subtypes. There is very little information on HCV seroprevalence and genotypes in Kenya. To determine the genotypes of HCV circulating in Kenya, blood donor samples were serologically tested and confirmed by polymerase chain reaction (PCR). Positive samples were cloned and sequenced, and phylogenetic analysis conducted to determine the HCV genotypes. One hundred Murex-seropositive samples were re-tested using a passive hemagglutination test, and 16 of these were identified as seropositive. Further testing of all of the samples by PCR identified only 10 of the 16 samples as positive. Thus, only 10 % (10/100) of the samples were viremic. Six were from females (60 %), and four were from males (40 %). The mean age of the positive donors was considerably low, at 25 +/- 9 years. Genotypic testing indicated the presence of genotype 1a (10 %) and genotype 2b (90 %). This study reports on HCV genotypes in a blood donor population in Kenya where little had been done to provide information on HCV genotypes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26497178     DOI: 10.1007/s00705-015-2623-8

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.

Authors:  Matthew J Akiyama; Charles M Cleland; John A Lizcano; Peter Cherutich; Ann E Kurth
Journal:  Lancet Infect Dis       Date:  2019-09-17       Impact factor: 25.071

2.  The Prevalence of Hepatitis C Virus Antibody in HIV-Negative Persons in Kenya, 2007.

Authors:  Kathleen N Ly; Andrea A Kim; Jan Drobeniuc; Maja Kodani; Joel M Montgomery; Barry S Fields; Eyasu H Teshale
Journal:  Am J Trop Med Hyg       Date:  2018-04-19       Impact factor: 2.345

3.  Screening a nation for hepatitis C virus elimination: a cross-sectional study on prevalence of hepatitis C and associated risk factors in the Rwandan general population.

Authors:  Justine Umutesi; Carol Yingkai Liu; Michael J Penkunas; Jean Damascene Makuza; Corneille K Ntihabose; Sabine Umuraza; Julienne Niyikora; Janvier Serumondo; Neil Gupta; Sabin Nsanzimana
Journal:  BMJ Open       Date:  2019-07-03       Impact factor: 2.692

4.  Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya.

Authors:  Patrick Okoti Aluora; Margaret Wangui Muturi; George Gachara
Journal:  Virol J       Date:  2020-11-13       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.